Company News: Pfizer

Share this article:
Pfizer said it will supply its Prevnar 13 pediatric vaccine to impoverished countries for 10 years under the terms of a UNICEF pilot project aimed at fighting pneumococcal disease, the leading cause of vaccine-preventable death for children under 5 globally. Under the terms of an Advance Market Committment agreement, Pfizer has agreed to charge no more than $3.50 per dose for 10 years to meet long-term demand and ensure affordability of the vaccine in developing countries even after the donor contributions are exhausted.
Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.